Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 1,013,540
Value: $632.0M
% of portfolio: 0.2%
Quarters held: 21; Since Q2 2021

Holdings of REGN by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,013,540	$632.0M	0.2%	+3,742+0.4%	Added	Holders
Q1 2026	1,009,798	$780.2M	0.2%	+217,892+27.5%	Added	Holders
Q4 2025	791,906	$611.2M	0.2%	+170,165+27.4%	Added	Holders
Q3 2025	621,741	$364.0M	0.1%	−275,390−30.7%	Reduced	Holders
Q2 2025	897,131	$491.4M	0.2%	−706,770−44.1%	Reduced	Holders
Q1 2025	1,603,901	$979.8M	0.4%	+52,166+3.4%	Added	Holders
Q4 2024	1,551,735	$1.14B	0.4%	+487,489+45.8%	Added	Holders
Q3 2024	1,064,246	$1.07B	0.4%	−720.0%	Reduced	Holders
Q2 2024	1,064,318	$1.09B	0.4%	+7,859+0.7%	Added	Holders
Q1 2024	1,056,459	$944.6M	0.4%	+142,334+15.6%	Added	Holders
Q4 2023	914,125	$825.1M	0.4%	+228,839+33.4%	Added	Holders
Q3 2023	685,286	$575.4M	0.3%	+574+0.1%	Added	Holders
Q2 2023	684,712	$491.7M	0.2%	−87,503−11.3%	Reduced	Holders
Q1 2023	772,215	$637.2M	0.3%	+76,780+11.0%	Added	Holders
Q4 2022	695,435	$493.7M	0.3%	+40,245+6.1%	Added	Holders
Q3 2022	655,190	$488.5M	0.3%	+100,682+18.2%	Added	Holders
Q2 2022	554,508	$332.1M	0.3%	+55,578+11.1%	Added	Holders
Q1 2022	498,930	$360.1M	0.2%	+38,600+8.4%	Added	Holders
Q4 2021	460,330	$283.6M	0.2%	+33,873+7.9%	Added	Holders
Q3 2021	426,457	$258.1M	0.2%	+225,038+111.7%	Added	Holders
Q2 2021	201,419	$112.5M	0.1%	–	No prior filing	Holders